In multiple datasets, we identified associations between (i) gain of chromosome 1q in neuroblastoma, poor survival, MCL1 dependency, and MCL1 inhibitor sensitivity and (ii) gain of chromosome 3p25 and cisplatin resistance in cell lines and poor prognosis in malignant germ cell tumors and lung cancers. This evidence concerns the gene MCL1 and neuroblastoma.